Comparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouse
about
Doxorubicin-induced carbonylation and degradation of cardiac myosin binding protein C promote cardiotoxicityEnhanced antitumor activity of doxorubicin in breast cancer through the use of poly(butylcyanoacrylate) nanoparticlesPharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse.Alterations in estrogen signalling pathways upon acquisition of anthracycline resistance in breast tumor cellsDynamic monitoring of oxidative DNA double-strand break and repair in cardiomyocytes.Protection against doxorubicin-induced myocardial dysfunction in mice by cardiac-specific expression of carboxyl terminus of hsp70-interacting proteinBreast cancer targeted chemotherapy based on doxorubicin-loaded bombesin peptide modified nanocarriers.Synthesis and antitumor mechanisms of a copper(II) complex of anthracene-9-imidazoline hydrazone (9-AIH).Nuclear accumulation of anthracyclines in the endothelium studied by bimodal imaging: fluorescence and Raman microscopy.A novel insight into the cardiotoxicity of antineoplastic drug doxorubicin.Sertoli Cells Loaded with Doxorubicin in Lipid Micelles Reduced Tumor Burden and Dox-Induced Toxicity.An in vitro study on the effect of vinca alkaloid, vinorelbine, on chromatin histone, HMGB proteins and induction of apoptosis in mice non-adherent bone marrow cells.THE ROLE OF PROTEIN CHAPERONES IN THE SURVIVAL FROM ANTHRACYCLINE-INDUCED OXIDATIVE STRESS IN SACCHAROMYCES CEREVISIAE.Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity.
P2860
Q28306329-14384823-6D25-4992-BD3C-D819E8D6934CQ35105148-B81A8B52-2503-4822-ABCE-ACA7E2089E47Q35847003-F3699DDA-1ACA-4957-B818-173840A7AB93Q36280127-7D90F262-169A-4EA5-B670-F3DF924AF719Q36709778-6BAE9EDC-0F75-40F1-B798-02A159AFE41AQ37024066-B1EA2E91-2DAD-4D43-9B58-5A2BE4287F8EQ38850070-CEE44592-C0A9-4839-AF6A-878319076E8FQ38883280-6FBDA65F-C461-4CAF-A65F-EE7670C6AED5Q38918849-89454607-4A06-472C-B50D-36ADFAE1B8FBQ42116782-E680A5E7-F72D-4269-99AC-E5423E59DBDAQ47676301-230FC542-2A34-458E-9EA5-999FC932C006Q50426409-C7DEDD59-B61E-43A1-BF42-182508CBA7E8Q52587039-7C89687D-5867-46E3-A9E6-273CAE0C8DFFQ55265082-241BE19D-6A24-454F-95F9-3EAFC870C485
P2860
Comparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouse
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Comparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouse
@ast
Comparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouse
@en
Comparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouse
@nl
type
label
Comparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouse
@ast
Comparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouse
@en
Comparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouse
@nl
prefLabel
Comparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouse
@ast
Comparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouse
@en
Comparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouse
@nl
P2093
P2860
P3181
P1433
P1476
Comparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouse
@en
P2093
Antonio Abbate
Benjamin W Van Tassell
David A Gewirtz
Eleonora Mezzaroma
Evan T Sumner
Francesco Loperfido
Giovanni Palazzoni
Ignacio M Seropian
Marzia Lotrionte
Norbert F Voelkel
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0058421
P407
P577
2013-03-14T00:00:00Z